Tony Jose is a genomics tech-preneur with nearly two decades of experience at the intersection of genomics, genetic diagnostics, and precision medicine. A researcher-turned-entrepreneur, Tony is widely recognized as one of the pioneers who helped shape the genomics and genetic diagnostics landscape in South Asia.
He is the Founder and CEO of SugarStrings.ai, a globally leading upstream diagnostics platform focused on the early detection, prevention, and precision treatment of chronic diseases, including cancers, cardiometabolic disorders, and neurological conditions. SugarStrings.ai integrates advanced DNA sequencing, machine learning, and AI-driven analytics to identify diseases at the molecular level long before symptoms appear—empowering clinicians with actionable insights for proactive care.
Tony also serves as the Founder and Executive Director of Clevergene, an international contract research organization (CRO) working across drug discovery, functional genomics, and advanced molecular research. Clevergene supports leading pharmaceutical and biotechnology companies across the US, Europe, and Middle East, enabling faster and more efficient therapeutic innovation.
With formal research training in clinical genetics, Tony is deeply passionate about the transformative potential of AI-enabled DNA analysis to predict disease risk, optimize treatments, and reshape the future of preventive healthcare. His work sits at the forefront of integrating deep technology with clinical science to build scalable, high-impact healthcare solutions.